Are you sure you want to leave?
28 June 2021
In June 2021, Vifor Pharma hosted a virtual symposium at the 58th European Renal Association–European Dialysis and Transplant Association (ERA–EDTA) Congress. Entitled ‘CKD–MBD management – a clinical perspective’, the symposium gave attendees the opportunity to explore expert clinical perspectives on the management of two key components of chronic kidney disease–mineral and bone disorder (CKD–MBD): secondary hyperparathyroidism (SHPT) and hyperphosphataemia. Vifor Pharma also hosted a virtual SHPT booth to raise awareness about SHPT in CKD. A summary video of one of the presentations at the symposium and a link to watch the full symposium are provided below, along with highlights about the SHPT booth. The summary video includes discussion of a real patient case that exemplifies the most relevant questions that might arise when treating SHPT.
The Vifor Pharma symposium began with an introduction by the Chair, Professor Julia Weinmann-Menke,* which included an overview of the potential biochemical and clinical outcomes of CKD–MBD.
The introduction was followed by two enlightening and information-packed presentations, one by Professor Michael Germain† and another by Professor Emilio Sanchez.‡
Professor Germain focused on practical approaches to managing SHPT in non-dialysis CKD, incorporating the real-life case of a 58-year-old patient.
The patient’s journey was outlined, along with the challenges associated with his treatment. The presentation covered a wide range of topics, providing insights into:
Below is a summary video of Professor Germain’s presentation. It features four important questions that he answered about his patient and his treatment.
Professor Sanchez looked at ways of addressing the clinical challenges of managing hyperphosphataemia in CKD patients, using real-world insights from a patient case. The presentation explored expert strategies of improving patient outcomes and covered such subjects as:
You can watch the presentations by professors Germain and Sanchez in full, along with the introduction by the Chair, at the ERA–EDTA congress site.
The Vifor Pharma virtual SHPT booth allowed attendees to watch presentations and download a range of educational materials related to managing SHPT in CKD. Most of these features are available on this website.
At the virtual SHPT booth, the attendees were able to:
We’d like to thank everyone involved in delivering our 2021 ERA–EDTA virtual symposium and SHPT booth. We extend a special thank you to the Chair of the symposium, Professor Julia Weinmann-Menke, and our fantastic speakers, professors Germain and Sanchez.
*Head of Nephrology, University Medical Centre Mainz, Johannes Gutenberg University, Mainz, Germany.
†Professor of Medicine, Tufts University School of Medicine, Boston, Massachusetts, USA.
‡Head of Nephrology, University Hospital of Cabueñes, Gijón, Spain.
¶Director of Medical Clinic V, Hypertension and Nephrology, Tertiary Care and Teaching Hospital Braunschweig, Braunschweig, Germany.
You are viewing a website from Vifor Pharma. This material is only intended for healthcare professionals (“HCPs”) from Europe. If you are not the intended audience, please leave this website. By checking the box, you acknowledge that you are a HCP from Europe. Approval conditions for products may vary from country to country. Before prescribing any product, always refer to local materials such as the prescribing information and/or the Summary of Product Characteristics.
I am residing in:
Bitte verwenden Sie als Benutzernamen die E-Mail Adresse, welche Sie bei der Registration angegeben hatten. Falls Sie das Passwort vergessen haben, können Sie sich einen Reaktivierungslink zustellen lassen. Alternativ ist für bereits registrierte Health Professionals auch eine Anmeldung mit der HPC-Card von FMH oder pharmaSuisse möglich.